166 related articles for article (PubMed ID: 32270505)
1. A study of impairments in oculopharyngeal muscular dystrophy.
Brisson JD; Gagnon C; Brais B; Côté I; Mathieu J
Muscle Nerve; 2020 Aug; 62(2):201-207. PubMed ID: 32270505
[TBL] [Abstract][Full Text] [Related]
2. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
[TBL] [Abstract][Full Text] [Related]
3. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.
Youssof S
Muscle Nerve; 2016 May; 53(5):694-9. PubMed ID: 26453481
[TBL] [Abstract][Full Text] [Related]
4. Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.
Youssof S; Schrader R; Bear D; Morrison L
Neuromuscul Disord; 2015 Mar; 25(3):238-46. PubMed ID: 25500011
[TBL] [Abstract][Full Text] [Related]
5. Oculopharyngeal Muscular Dystrophy, an Often Misdiagnosed Neuromuscular Disorder: A Southern California Experience.
Goyal NA; Mozaffar T; Chui LA
J Clin Neuromuscul Dis; 2019 Dec; 21(2):61-68. PubMed ID: 31743248
[TBL] [Abstract][Full Text] [Related]
6. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population.
Shan J; Chen B; Lin P; Li D; Luo Y; Ji K; Zheng J; Yuan Y; Yan C
Neuromolecular Med; 2014 Dec; 16(4):782-6. PubMed ID: 25283883
[TBL] [Abstract][Full Text] [Related]
7. Oculopharyngeal muscular dystrophy among Bulgarian Jews: a new cluster?
Blumen SC; Kesler A; Dabby R; Shalev S; Khayat M; Almog Y; Zoldan J; Benninger F; Drory VE; Gurevich M; Sadeh M; Brais B; Braverman I
Isr Med Assoc J; 2013 Dec; 15(12):748-52. PubMed ID: 24449978
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands.
Alonso-Pérez J; de León Hernández JC; Pérez-Pérez H; Mendoza-Grimón MD; Gutierrez-Martinez AJ; Hadjigeorgiou I; Montón-Álvarez F; González-Quereda L; Alonso-Jimenez A; Suárez-Calvet X; Díaz-Manera J
Eur J Neurol; 2022 May; 29(5):1488-1495. PubMed ID: 35112761
[TBL] [Abstract][Full Text] [Related]
9. Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint.
Van Der Sluijs BM; Hoefsloot LH; Padberg GW; Van Der Maarel SM; Van Engelen BG
J Neurol; 2003 Nov; 250(11):1307-12. PubMed ID: 14648146
[TBL] [Abstract][Full Text] [Related]
10. Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.
Richard P; Trollet C; Stojkovic T; de Becdelievre A; Perie S; Pouget J; Eymard B;
Neurology; 2017 Jan; 88(4):359-365. PubMed ID: 28011929
[TBL] [Abstract][Full Text] [Related]
11. Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland.
Agarwal PK; Mansfield DC; Mechan D; Al-Shahi Salman R; Davenport RJ; Connor M; Metcalfe R; Petty R
Br J Ophthalmol; 2012 Feb; 96(2):281-3. PubMed ID: 21602480
[TBL] [Abstract][Full Text] [Related]
12. Characterization of
Cruz-Aguilar M; Guerrero-de Ferran C; Tovilla-Canales JL; Nava-Castañeda A; Zenteno JC
J Investig Med; 2017 Mar; 65(3):705-708. PubMed ID: 27980005
[TBL] [Abstract][Full Text] [Related]
13. Oculopharyngeal muscular dystrophy: underdiagnosed disease in Hong Kong.
Luk HM; Lo IF; Fu KH; Lui CH; Tong TM; Chan DH; Lam ST
Hong Kong Med J; 2013 Dec; 19(6):556-9. PubMed ID: 24310666
[TBL] [Abstract][Full Text] [Related]
14. A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.
Nishii YS; Noto YI; Yasuda R; Kitaoji T; Ashida S; Tanaka E; Minami N; Nishino I; Mizuno T
BMC Neurol; 2021 Jul; 21(1):265. PubMed ID: 34225694
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported disease burden in oculopharyngeal muscular dystrophy.
Kurtz NS; Cote C; Heatwole C; Gagnon C; Youssof S
Muscle Nerve; 2019 Dec; 60(6):724-731. PubMed ID: 31531865
[TBL] [Abstract][Full Text] [Related]
16. Swallow characteristics in patients with oculopharyngeal muscular dystrophy.
Palmer PM; Neel AT; Sprouls G; Morrison L
J Speech Lang Hear Res; 2010 Dec; 53(6):1567-78. PubMed ID: 20699340
[TBL] [Abstract][Full Text] [Related]
17. Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy.
Witting N; Mensah A; Køber L; Bundgaard H; Petri H; Duno M; Milea D; Vissing J
Acta Neurol Scand; 2014 Aug; 130(2):125-30. PubMed ID: 24611576
[TBL] [Abstract][Full Text] [Related]
18. The Dutch patients' perspective on oculopharyngeal muscular dystrophy: A questionnaire study on fatigue, pain and impairments.
van der Sluijs BM; Knoop H; Bleijenberg G; van Engelen BG; Voermans NC
Neuromuscul Disord; 2016 Mar; 26(3):221-6. PubMed ID: 26948710
[TBL] [Abstract][Full Text] [Related]
19. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
